A new court ruling combines sociological analysis and the facts of a minor crime to create a new genre of narrative that could be called Rural Ontario Gothic. Here is that ruling, in the case of His ...

India’s Navy, through Vice Admiral Sanjay Vatsayan, made it crystal clear that Operation Sindoor continues - a live, evolving ...

A former NHS worker has said she faces 12-mile round-trips on her mobility scooter for healthcare because her local medical centre was still shut after a flood in June. Diane Pickup, from Scarborough, ...

Armenians are some of the angriest people in the world while Uzbeks are among the most easygoing, according to a recently published global survey of emotional wellbeing. Gallup’s State of the World’s ...

For years, Selma Blair battled unexplained pain and crippling fatigue while doctors dismissed her symptoms. Blair revealed that despite experiencing symptoms since childhood, her multiple sclerosis ...

Authorities have made multiple arrests after five shootings in 24 hours related to homecoming football events in Mississippi left at least nine people dead and several others injured. Three shooting ...

The AI economic transformation has begun. In May, IBM declared that it had fired hundreds of employees and replaced them with artificial intelligence chatbots. Over the summer, Salesforce let go of ...

In Focus delivers deeper coverage of the political, cultural, and ideological issues shaping America. Published daily by senior writers and experts, these in-depth pieces go beyond the headlines to ...

Rachel Griffin Accurso, also known as Ms. Rachel, had been singing nursery rhymes and homeschool lesson tapes on kindness to her 16 million subscribers for years. This week, however, she dove ...

Peru’s Congress ousted President Dina Boluarte from power in the latest round of political turmoil in the Andean nation. Boluarte was impeached Friday by opposition lawmakers on grounds of “moral ...

Eyeing a drug that it believes holds peak annual sales potential of $12 billion in the U.S. alone, Zenas BioPharma has struck a licensing deal with China-based InnoCare Pharma that could be worth more ...